FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4039011000001106: Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26831701000001119 Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
70076601000001118 Alkeran 2mg tablets (Aspen Pharma Trading Ltd) 25 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Is a Melphalan 2mg tablets 25 tablet true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Is pack of Alkeran 2mg tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has active ingredient Melphalan false Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has AMP Alkeran 2mg tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has specific active ingredient Melphalan true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Alkeran 2mg tablets (GlaxoSmithKline) 25 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start